Obesity and Prostate Cancer. (Q50856725)

24 March 2018

review article

1 reference

title

Obesity and Prostate Cancer. (English)

1 reference

24 March 2018

0 references

2

Edward Giovannucci

1 reference

24 March 2018

Yin Cao

1

1 reference

24 March 2018

publication date

1 January 2016

1 reference

24 March 2018

Recent Results in Cancer Research

published in

1 reference

24 March 2018

volume

208

1 reference

24 March 2018

page(s)

137-153

1 reference

24 March 2018

The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Risk factors for prostate cancer incidence and progression in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body mass index and incidence of localized and advanced prostate cancer--a dose-response meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body size and composition and prostate cancer risk: systematic review and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Associations of body mass index, smoking, and alcohol consumption with prostate cancer mortality in the Asia Cohort Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prostate tumours from an Asian population: examination of bax, bcl-2, p53 and ras and identification of bax as a prognostic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Weight gain is associated with an increased risk of prostate cancer recurrence after prostatectomy in the PSA era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Hypertension, obesity and prostate cancer biochemical recurrence after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Impact of folate intake on prostate cancer recurrence following definitive therapy: data from CaPSURE™.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body size across the life course and prostate cancer in the Health Professionals Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body size and risk of prostate cancer in the European prospective investigation into cancer and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Abdominal obesity, hypertension, antihypertensive medication use and biochemical recurrence of prostate cancer after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body mass index and weight change in men with prostate cancer: progression and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prostate cancer: is it time to expand the research focus to early-life exposures?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body mass index in early and middle-late adulthood and risk of localised, advanced and fatal prostate cancer: a population-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body mass index and risk of prostate cancer in U.S. health professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Obesity before age 30 years and risk of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Childhood body mass index and the risk of prostate cancer in adult men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Demographic, behavioral, psychosocial, and dietary correlates of cancer screening in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Obesity, prostate-specific antigen nadir, and biochemical recurrence after radical prostatectomy: biology or technique? Results from the SEARCH database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Daily electronic portal imaging for morbidly obese men undergoing radiotherapy for localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Association of prostate cancer risk with insulin, glucose, and anthropometry in the Baltimore longitudinal study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Association of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prediagnostic C-peptide and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body mass index, waist circumference and waist–hip ratio and serum levels of IGF-I and IGFBP-3 in European women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Bioactive insulin-like growth factor-I in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Insulin-like growth factor-I concentration and risk of prostate cancer: results from the European Prospective Investigation into Cancer and Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prediagnostic plasma IGFBP-1, IGF-1 and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Circulating steroid hormones and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

High-grade prostate cancer is associated with low serum testosterone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Testosterone as a predictor of pathological stage in clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prediagnostic circulating sex hormones are not associated with mortality for men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Modification of the association between obesity and lethal prostate cancer by TMPRSS2:ERG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Genetic variation in genes of the fatty acid synthesis pathway and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Anthropometrics and Prostate Cancer Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Trends in prostate cancer mortality among black men and white men in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Obesity, metabolic syndrome, and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Synthesis and regulation of sex hormone-binding globulin in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

A meta-analysis of diabetes mellitus and the risk of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-42542-9_8

10.1007/978-3-319-42542-9_8

31 March 2020

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

27909906

1 reference

24 March 2018